Panel also gives nod to maintenance BCG, single chemo instillation after tumor resection
Feb 1, 2008
By:Colleen M. Padia
Among the many recommendations within the new AUA guideline for the management of nonmuscle-invasive bladder cancer, arguably one of the most important is the idea of repeating resection for patients with high-grade Ta or T1 disease within a few weeks of the initial resection before making a treatment recommendation.
 |
Apr 1, 2009
By:Scott Tennant
Results of a population-based, case-control study suggest there may be an association between marijuana use and the occurrence of testicular germ cell tumors (TGCTs), researchers from the Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, reported.
|
Contribution to excess mortality about twofold higher in African-Americans vs. women
Apr 1, 2009
By:Cheryl Guttman
In patients with bladder cancer, tumor characteristics at presentation are less favorable in women and African-Americans versus Caucasian men, according to a study by researchers at the University of Rochester, New York.
|
Jan 1, 2009
By:Fred Gebhart
In the treatment of renal cell carcinoma, partial nephrectomy produces better quality of life than cryoablation, according to researchers at Washington University, St. Louis.
|
Jan 1, 2009
By:Stephen E. Strup, MD
The practicing urologist faces an increasingly common dilemma: How should I treat this incidentally discovered small renal mass?
|
But severity of bladder cancer could affect study outcomes, researchers say
Jan 1, 2009
By:Fred Gebhart
Statin drugs appear to have no effect on intravesical bacillus Calmette-Guerin (BCG) treatment outcomes in patients with non-muscle invasive bladder cancer, according to a recent retrospective study among Veterans Affairs patients in St. Louis.
|
Researchers report no positive margins, one bladder entry in medium-term study
Jan 1, 2009
By:Fred Gebhart
Based on new mid-term study results, robot-assisted laparoscopic cystectomy appears to be slowly moving toward mainstream surgical practice.
|
Nov 1, 2008
By:L. Andrew Evans, MD, Edith Canby-Hagino, MD
By risk-stratifying nonmuscle-invasive bladder cancers, urologists can characterize pathologic subtypes and develop individualized treatment and surveillance strategies.(CME)
|
Nov 1, 2008
By:Scott Tennant
Adjuvant chemotherapy is an essential part of the treatment protocol for lymph node-positive bladder cancer.
|
| 
Brings you the latest news and information twice each month.
Urology Times archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.